Lilly Warns Doctons on Strattera Use
Drug maker Eli Lilly & Co. warned doctors Friday to stop using the attention deficit disorder drug Strattera in patients with jaundice or who show signs of liver problems.
Lilly placed a boldface warning on the label and in prescribing information for the drug to alert doctors after at least two patients on the medication developed liver problems. Both patients recovered normal liver function after stopping the medication, the Indianapolis-based company said.
Dr. John Grohol is the CEO and founder of Psych Central. He is an author, researcher and expert in mental health online, and has been writing about online behavior, mental health and psychology issues -- as well as the intersection of technology and human behavior -- since 1992. Dr. Grohol sits on the editorial board of the journal Cyberpsychology, Behavior and Social Networking and is a founding board member and treasurer of the Society for Participatory Medicine.Like this author?
Catch up on other posts by John M. Grohol, PsyD (or subscribe to their feed).
Comments
This post currently has no comments. You can read the comments or leave your own thoughts on our new comments page.
Trackbacks
Last reviewed: By John M. Grohol, Psy.D. on 20 Dec 2004
Published on PsychCentral.com. All rights reserved.
APA Reference
Grohol, J. (2004). Lilly Warns Doctors on Strattera Use. Psych Central. Retrieved on February 14, 2012, from http://psychcentral.com/blog/archives/2004/12/20/lilly-warns-doctors-on-strattera-use/
Grohol, J. (2004). Lilly Warns Doctors on Strattera Use. Psych Central. Retrieved on February 14, 2012, from http://psychcentral.com/blog/archives/2004/12/20/lilly-warns-doctors-on-strattera-use/
